Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma

Immunotherapy using anti-programmed death 1 ligand 1 (PD-L1) antibodies has shown clinical efficacy against hepatocellular carcinoma (HCC) and is recognized as the first-line treatment for unresectable HCC. PD-L1 expression is affected by various cytokines produced by immune cells in the tumor micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Numata, Yasunao, Akutsu, Noriyuki, Ishigami, Keisuke, Koide, Hideyuki, Wagatsuma, Kohei, Motoya, Masayo, Sasaki, Shigeru, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095738/
https://www.ncbi.nlm.nih.gov/pubmed/35573813
http://dx.doi.org/10.1016/j.bbrep.2022.101270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095738/
https://www.ncbi.nlm.nih.gov/pubmed/35573813
http://dx.doi.org/10.1016/j.bbrep.2022.101270

Ejemplares similares